Drug Trial Radar · NCT01309542
Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Apr 26, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,403
Actual
Start
Aug 2003
Primary completion
Mar 2006
Study completion Mar 2006
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Mar 7, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study evaluated the long-term safety of Desvenlafaxine Succinate (DVS) Slow Release (SR) during open-label treatment in adult outpatients who had a primary diagnosis of major depressive disorder (MDD). The study also evaluated the long-term response of subjects receiving DVS SR for clinical global evaluation, functionality, general well-being, pain, and absence of depressive symptoms (remission).
Conditions
- Major Depressive Disorder
Interventions
Desvenlafaxine SuccinateDrug
Tablet were taken at a daily dose of 200 to 400 mg/day for a duration up to 10 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number (%) of Subjects Reporting Adverse Events during TreatmentTime frame: 10 months
- Number (%) of Subjects With Changes in Vital Signs (Blood Pressure, Pulse Rate, Weight) of Potential Clinical ImportanceTime frame: 10 months
- Number (%) of Subjects With Laboratory Test Results (Hematology, Blood Chemistry, Lipid Profile, Urinalysis) of Potential Clinical ImportanceTime frame: 10 months
- Number (%) of Subjects With Electrocardiogram Results (Heart Rate, QTc interval) of Potential Clinical ImportanceTime frame: 10 months
Locations
117 sites in 11 countries. Site status is shown where the registry gives one.
Birmingham Research Group Inc.
Birmingham, Alabama
Pivotal Research Centers 13128 North 94th Drive, Suite 200
Mesa, Arizona
Pivotal Research
Peoria, Arizona
Southwestern Research, Inc.
Beverly Hills, California
Feighner Research Institute
Chula Vista, California
California Clinical Trials Medical Group, Inc.
Glendale, California
Pharmacology Research Institute
Newport Beach, California
Pacific Clinical Research
Orange, California
UCSD Department of Psychiatry Psychopharmacology Research
San Diego, California
Southwestern Research, Inc.
Tustin, California
Alpine Clinical Research Center, Inc.
Boulder, Colorado
Feiger Health Research Center
Lakewood, Colorado
University of Connecticut Health Center
Farmington, Connecticut
New Britain General Hospital
New Britain, Connecticut
The George Washington University Medical Center
Washington D.C., District of Columbia
CORE Research, Inc.1006 NW 14
Leesburg, Florida
Lifestream Behavioral Center
Leesburg, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Miami Research Associates, Inc.
South Miami, Florida
Comprehensive NeuroScience, Inc.
St. Petersburg, Florida
Kolin Research Group 1065 West Morse Blvd. Suite 202
Winter Park, Florida
Atlanta Center for Medical Research
Atlanta, Georgia
Atlanta Institute of Medicine & Research
Marietta, Georgia
Carman Research
Smyrna, Georgia
Radiant Research - Chicago
Chicago, Illinois
Ingenium Clinical Research
Libertyville, Illinois
Capital Clinical Research Associates, LLP
Rockville, Maryland
DuPont Clinical Research, Inc.
Rockville, Maryland
Institute for Health Studies
Okemos, Michigan
Creighton University
Omaha, Nebraska
Center for Emotional Fitness
Cherry Hill, New Jersey
CRI Worldwide, LLC
Clementon, New Jersey
Social Psychiatry Research Institute
New York, New York
The Medical Research Network
New York, New York
Anxiety & Depression Clinic
The Bronx, New York
Piedmont Neuropsychiatry
Charlotte, North Carolina
Hartford Research Group
Cincinnati, Ohio
Midwest Clinical Research Center, LLC
Dayton, Ohio
Neurology & Neuroscience Center of Ohio
Toledo, Ohio
IPS Research Company
Oklahoma City, Oklahoma
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.